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Abstract Epidermal growth factor (EGF) and transforming
growth factor-K (TGF-K) are associated with regulation of
various gastrointestinal functions. In order to better understand
their role in developing small intestine EGF, TGF-K and EGF-R
steady-state mRNA levels and transcript stability were deter-
mined. Reverse transcription (RT) competitive-polymerase chain
reaction (PCR) revealed that intestinal TGF-K mRNA levels
were 10-fold higher in comparison with EGF mRNA. The
primary intestinal culture technique was used to evaluate mRNA
stability. The stability of TGF-K mRNA was remarkably lower
than the stability of EGF mRNA. High levels of TGF-K mRNA
accompanied by high degradation rate of this mRNA suggested a
rapid turnover of intestinal TGF-K mRNA.
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1. Introduction
Epidermal growth factor and transforming growth factor-K
are biologically potent polypeptides that produce a variety of
biologic responses, most of which involve enhanced prolifer-
ation and/or di¡erentiation of epithelial cells [1,2]. Both
growth factors belong to the family of EGF-related ligands,
sharing amino acid sequence homology [3] and high a⁄nity to
the same receptor ^ epidermal growth factor receptor [4,5].
EGF-R is a transmembrane glycoprotein composed of an ex-
tracellular peptide binding domain, a transmembrane domain,
and an intracellular domain possessing tyrosine-speci¢c pro-
tein kinase activity which is believed to be the primary e¡ector
of EGF or TGF-K responses [6,7]. It is likely, therefore, that
regulation of EGF-R expression has a signi¢cant in£uence on
the control of cell growth and di¡erentiation.
Locally derived, paracrine/autocrine-acting peptide growth
factors play crucial roles in the control and maintenance of
growth and di¡erentiation of epithelial tissue, such as mucosa
of gastrointestinal tract. In suckling rats, signi¢cant amounts
of EGF and TGF-K peptides have been reported throughout
the gastrointestinal tract [8^18], however, the origin of these
growth factors is not clear. High concentrations of EGF pep-
tide were found in rat amniotic £uid and rat milk [19], sug-
gesting that during development the major part of intestinal
EGF is delivered orogastrically. In contrast to this, TGF-K
peptide was not detected in rat milk and the source of intes-
tinal TGF-K in neonates is probably pancreas and intestinal
tissue itself [18]. In addition, the presence of speci¢c EGF-
receptor throughout the gastrointestinal tract of suckling
rats and mice has been reported, suggesting that EGF-related
peptides play an important physiological role in this tissue
during development [20^23].
Intestinal EGF, TGF-K and EGF-R mRNA levels have not
been clearly quanti¢ed yet. Previously, we have reported cel-
lular localization of EGF and TGF-K mRNA transcripts in
developing small intestine of rats using an in situ hybridiza-
tion technique. However, an accurate quanti¢cation of these
two mRNAs was not performed [24]. Since gene expression of
these transcripts in developing small intestine is very low, the
reverse transcription (RT) competitive-polymerase chain reac-
tion (PCR) assay has been established to amplify the messages
and measure mRNA levels quantitatively. Recently, we have
used this approach to measure intestinal IGF-I mRNA level
[25]. A similar technique has been published for detection of
EGF mRNA in developing mouse reproductive tract [26].
The main goal of this study was to detect and quantify
EGF and TGF-K steady-state mRNA levels in developing
small intestine from rats. Furthermore, to better understand
the role of these growth factors in this tissue, gene expression
of EGF receptor was measured. Signi¢cant di¡erences in
mRNA levels raised the question about the transcript stabil-
ity. Steady-state mRNA levels result from a balance between
the rates of mRNA transcription and mRNA degradation.
The mRNA stability can be studied by using transcription
inhibitor such as actinomycin D, however, direct in vivo ap-
plication of actinomycin D to the animal can a¡ect several
physiological functions of whole organisms. Therefore, we
decided to use the primary organ culture method. Intestinal
organ culture from fetal and neonatal rats, has been described
several times in studies evaluating the direct e¡ect of biolog-
ically active substances on the maturation of small intestine
[27^37]. Based on our previous experience with this method
[32,37], the serum-free organ culture method was used in these
studies. The combination of in vitro organ culture method
and RT competitive-PCR enabled us to measure more accu-
rately EGF, TGF-K and EGF-R transcripts stability in the
small intestine from neonatal rat.
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2. Material and methods
2.1. Materials
Sodium phosphate, NaCl, F-12/DMEM medium (1:1 mixture), ka-
namycin, dimethyl sulfoxide (DMSO), actinomycin D, MOPS, sodium
acetate, EDTA were purchased from Sigma (St. Louis, MO, USA).
Formaldehyde solution (37%, w/v), ethidium bromide were from UBS
(Cleveland, OH, USA). RNeasy Mini Kit and QIAamp Tissue Kit
were from Qiagen (Santa Clarita, CA, USA). RNase-free DNase en-
zyme was purchased from Invitrogen (San Diego, CA, USA). SeaKem
GTG Agarose was purchased from FMC BioProducts (Rockland,
ME, USA). All other chemicals and enzymes used for RT competi-
tive-PCR were purchased from Perkin Elmer (Norwalk, CT, USA).
2.2. Organ culture technique
Thirty 10-day-old male and female Sprague-Dawley rats (25^30 g),
originating from six di¡erent litters, were used in this study. Primary
culture of intestinal explants was performed using a modi¢cation of a
previously described method [32,37]. Brie£y, rats were killed by de-
capitation, the abdomen was aseptically opened and the small intes-
tine was £ushed with sterile phosphate bu¡er saline (PBS; 0.05 M
sodium phosphate, pH 7.4, 0.15 M NaCl) injected into the duodenal
lumen. The proximal part of jejunum (¢rst third of the jejunoileum)
was aseptically removed and cut with scissors into 1^2-cm long seg-
ments. One segment serving as an uncultured control was snap-frozen
in liquid nitrogen, and stored at 375‡C until processed for RNA
extraction. Other segments were randomized into 5 groups, cut
open longitudinally, and trimmed into 2^5-mm explants. The explants
were cultured in sterile 6-cm Petri dishes (Becton-Dickenson Labware,
Lincoln Park, NJ, USA) in 4 ml of serum-free F-12/DMEM medium
supplemented with kanamycin (100 Wg/ml) at 37‡C in a humidi¢ed
atmosphere of 95% O2 and 5% CO2 (v/v). The ¢rst 4 h of culture
served to adapt the intestinal explants to the in vitro conditions. After
this period, the organ culture was supplemented either with actino-
mycin D (¢nal concentration 10 Wg/ml) dissolved in DMSO (5 Wg/ml)
or with DMSO only (control), and cultured for an additional 16 h.
Randomized explants from each jejunum were split and served for
both actinomycin D-treated and control groups. Intestinal explants
were harvested at 0, 4, 8 or 16 h of culture, centrifuged at
16 000Ug for 30 s, snap-frozen in liquid nitrogen, and stored at
375‡C.
2.3. RNA extraction
Total RNA was isolated from organ culture or tissue using the
RNeasy Mini Kit as described in the manufacturer’s protocol, then
all samples were incubated with RNase-free DNase (20 U per reac-
tion) for 10 min at 37‡C to avoid DNA contamination. The RNA
concentration was quanti¢ed by UV spectrophotometry at 260 nm
(A260) and the purity was determined by the A260/A280 ratio (SPEC-
TRAmax PLUS, Molecular Devices, Sunnyvale, CA, USA). The in-
tegrity of RNA samples was veri¢ed by electrophoresis on 1.2% agar-
ose gel containing formaldehyde (2.2 M) and ethidium bromide in
1U MOPS bu¡er (40 mM MOPS (pH 7.0), 10 mM sodium acetate
and 1 mM EDTA (pH 8.0)).
2.4. RT competitive-PCR assay
Due to the low abundance of EGF, TGF-K, and EGF-R mRNAs
in the small intestine of suckling rats, an RT competitive-PCR assay
was established. DNA fragments containing either rat EGF or EGF-
R or TGF-K primer sequences were constructed using the PCR
MIMIC Construction Kit (Clontech, Palo Alto, CA, USA) as previ-
ously described for rat IGF-I DNA competitor [25]. In order to be
able to separate and quantify PCR products from competitive PCR
on agarose gel, the sizes of competitor (standard) DNAs were de-
signed 130^150 base pair (bp) longer than the actual sizes of PCR
products ampli¢ed from rat EGF, TGF-K or EGF-R mRNAs. The
competitor DNA was prepared in a two-step PCR reaction according
to the standard manufacturer’s protocol (Clontech), and puri¢ed on a
CHROMA SPIN column (Clontech). The concentration of newly
synthesized competitor DNA was measured by spectrophotometry,
veri¢ed by densitometry, and stored in aliquots at 375‡C.
2.5. Reverse transcription (RT)
Single-stranded complementary DNA (cDNA) was reverse-tran-
scribed from 1 Wg of total RNA in a 10-Wl reaction mixture containing
25 U of murine leukemia virus reverse transcriptase, 2.5 WM random
hexamers, 10 U of RNase inhibitor, 1 mM of each dNTP, 5 mM
MgCl2, 50 mM KCl and 10 mM Tris-HCl (pH 8.3). The reaction
mixture was incubated for 20 min at room temperature, 15 min at
42‡C, and then the reaction was terminated at 99‡C for 5 min. The
reaction mixture was kept at 4‡C until the start of PCR ampli¢cation.
The amounts of total RNA used in the RT reactions were calculated
from the absorbency at 260 nm, and veri¢ed by densitometry of the
28S ribosomal RNA band separated on denaturing agarose gels (by
Gel Doc 1000 Documentation System with Molecular Analyst/PC
software, Bio-Rad, Hercules, CA, USA).
2.6. Competitive PCR ampli¢cation
The reverse transcriptase product (10 Wl) was mixed with a 40-Wl
PCR reaction mixture containing 0.2 WM of each of the sense and
antisense primer, 1 U of Taq DNA polymerase, 1 mM MgCl2, 50 mM
KCl and 10 mM Tris-HCl (pH 8.3). One Wl of a de¢ned concentration
of competitor DNA was added to each tube. The mixture was sub-
jected to 30^35 cycles of PCR ampli¢cation on a Perkin Elmer DNA
Thermal Cycler 480. The PCR cycle conditions included: melting for
1 min at 94‡C, annealing for 1 min at 64‡C and primer extension for
2 min at 72‡C. The sequences of primers used are as follows: rat EGF
sense primer (5P-GTGGCGTGTGCATGTATGTT-3P corresponding
to nucleotides 3357^3376), and antisense primer (5P-CTCACGTTGC-
TGCTTGACTC-3P corresponding to nucleotides 3614^3633) [38]; rat
TGF-K sense primer (5P-ATGGTCCCCGCGGCCGGACAG-3P cor-
responding to nucleotides 145^165), and antisense primer (5P-GGCC-
TGCTTCTTCTGGCTGGCA-3P corresponding to nucleotides 418^
438) [39]; rat EGF-R sense primer (5P-CGGCCTGAACATAA-
CATCGC-3P corresponding to nucleotides 1476^1485), and antisense
primer (5P-GGTGGCAGACGTTATTGGCA-3P corresponding to
nucleotides 1989^2008) [40].
Twenty Wl of the ampli¢cation products were separated on 2%
agarose gel in 40 mM Tris-acetate, 1 mM EDTA (pH 8.0) bu¡er,
and stained with ethidium bromide. The band densities were evaluated
by using Gel Doc 1000 system with Molecular Analyst/PC software
(Bio-Rad). In order to assess relative amounts of natural PCR prod-
uct, the density ratios between the competitor and the target bands
were calculated. All PCR products were sequenced on both strands
using the same primers used for the PCR ampli¢cation and an auto-
mated sequencing system with £uorescent dye terminators (DNA Se-
quencing Service, University of Arizona, Tucson, AZ, USA). Control
reactions without reverse transcriptase or without total RNA yielded
no PCR product bands.
2.7. Statistical analysis
Statistical di¡erences between groups were determined utilizing a
two-way analysis of variance (ANOVA) and were considered signi¢-
cant at P6 0.05.
3. Results
3.1. Intestinal EGF, TGF-K and EGF-R mRNA levels
in suckling rats
To examine intestinal EGF, TGF-K and EGF-R mRNA
levels, a sensitive RT competitive-PCR assay was developed
and used. Fig. 1 shows a typical picture resulting from RT
competitive-PCR used for the quanti¢cation of TGF-K
mRNA in the jejunum from 10-day-old suckling rats. Total
RNA extracted from the small intestine was reverse-tran-
scribed into cDNA. A constant amount of cDNA was then
co-ampli¢ed with a ¢ve-fold serial dilution of the competitor
DNA by using a set of speci¢c primers. The amount of total
RNA from each intestinal sample served for individual eval-
uation of all EGF, TGF-K and EGF-R mRNA levels ; sam-
ples were not pooled. The di¡erences in nucleotide length
between the target band and competitor band were corrected
by multiplication of smaller band by a correction factor (C),
de¢ned as a C = larger band bp size/smaller band bp size.
Correction factors were as follows: EGF = 1.54 (i.e. 424/
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276), TGF-K= 1.45 (i.e. 427/294), and EGF-R = 1.25 (i.e. 532/
424). The logarithm of the density ratio of the target band to
the competitor band was then plotted against the logarithm of
the starting concentration of competitor DNA (Fig. 2). At the
competition equivalence point (log density ratio = 0), the orig-
inal concentration of target (EGF or TGF-K or EGF-R)
cDNA in the PCR reaction corresponds to the initial concen-
tration of competitor (EGF or TGF-K or EGF-R) DNA. The
values obtained for the equivalence point were multiplied by a
factor of 2, because the competitor DNA was double-stranded
and the target cDNA was single-stranded at the beginning of
the PCR reaction. To verify the identity of transcripts, PCR
products from RT-PCR (without any competitor) were se-
quenced on both strands. The sequences of the PCR products
were identical to those of rat EGF [38] or rat TGF-K [39] or
rat EGF-R [40].
The steady-state levels of EGF, TGF-K and EGF-R
mRNAs in the jejunum from 10-day-old suckling rats mea-
sured by RT competitive-PCR are shown in Fig. 3. The
intestinal TGF-K mRNA level was about 10-fold higher
than the EGF mRNA level. The expression of EGF-R
mRNA in suckling rat jejunum was the highest, about
6-fold more than TGF-K mRNA, and about 60-fold higher
than the EGF mRNA level.
3.2. In vitro transcript levels and mRNA stability in intestinal
organ culture
In order to determine the degradation rate of the mRNA
transcripts, proximal jejunum from 10-day-old suckling rats
was transferred into the in vitro system. Jejunal explants were
¢rst pre-cultured for 4 h to equilibrate the organ culture, then
explants were divided into two groups and cultured for up to
an additional 16 h in culture medium supplemented either
with or without actinomycin D ^ an inhibitor of mRNA syn-
thesis. The explants were harvested at time 0, 4, 8 and 16 h of
culture, and EGF, TGF-K and EGF-R transcript levels were
measured by RT competitive-PCR assay. In order to compare
EGF, TGF-K and EGF-R mRNA levels, the amount of
mRNA in samples harvested at time 0 was expressed as
100%. Messenger RNA levels from control culture without
addition of actinomycin D are shown in Fig. 4. The results
showed signi¢cant di¡erences between EGF and TGF-K
mRNA levels. During the ¢rst 4 h of culture, TGF-K
mRNA levels were markedly reduced to 45% of the starting
amount. However, after 4 h the TGF-K mRNA production
was dramatically increased, reaching 140% at time 8 h and
400% at time 16 h of culture in comparison to the starting
value. In contrast to this, EGF mRNA levels decreased for
the ¢rst 8 h of culture (60% and 55% of the starting value
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Fig. 3. Expression of TGF-K, EGF and EGF-R mRNAs in the
small intestine of suckling rats. The graph shows steady-state levels
of intestinal mRNAs in 10-day-old rats quanti¢ed by using RT
competitive-PCR assay. Data represent means þ S.E.M., n = 15.
Fig. 2. Quanti¢cation of EGF, TGF-K and EGF-R mRNAs in total
RNA extracted from jejunum of 10-day-old rats by using RT com-
petitive-PCR. Competition between natural (target) PCR product
and competitor PCR product (used in four di¡erent concentrations)
was determined by computer imaging of the optical intensity of
DNA bands on agarose gel. The logarithms of the density ratio of
natural (target) band to competitor band (after correction for the
di¡erence in size) were plotted as a function of the logarithm of the
amount of competitor added to the reaction. The total amounts of
EGF, TGF-K and EGF-R mRNAs in the sample were calculated
from the competitor values at the equivalence points (log density ra-
tio = 0).
Fig. 1. TGF-K mRNA intestinal level quanti¢ed by RT competitive-
PCR. Total RNA extracted from jejunum of 10-day-old suckling
rats was reverse-transcribed into cDNA, and then co-ampli¢ed with
serial dilution of the TGF-K competitor DNA. The natural 294-
and standard (competitor) 427-bp-long PCR products after ampli¢-
cation for 30 cycles were subjected to electrophoresis on 2% agarose
gel stained with ethidium bromide. Lanes A^D contain a constant
amount of intestinal cDNA co-ampli¢ed with decreasing amounts
of standard DNA, 5.0, 1.0, 0.5, and 0.1 amol, respectively. Lanes
E^G represent control reactions; lane E: simple RT-PCR without
addition of competitor DNA to detect possible cross-contamination
of sample with DNA competitor; lane F: no total RNA used in
simple RT-PCR to detect possible contamination from RT or PCR
reaction mixtures; lane G: no RT enzyme added in the reverse tran-
scription reaction to detect possible TGF-K DNA contamination in
the RNA sample.
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after 4 h and 8 h, respectively). Finally, at 16 h of culture,
EGF mRNA levels were increased to approximately 150% of
the starting level. The abundance of EGF-receptor transcripts
in organ culture exhibited a pattern similar to EGF mRNA
levels. After 4 h of culture, transcript level was about 67% of
the starting value, then the production of EGF-R mRNA was
steadily increased, reaching levels of about 95% at 8 h and
180% at 16 h of in vitro culture.
The stability of EGF, TGF-K and EGF-R mRNAs was
evaluated by using intestinal organ cultures supplemented
with actinomycin D. Addition of actinomycin D to the culture
led to a signi¢cant reduction of the abundance of all three
measured transcripts, but the patterns of transcript stability
were markedly di¡erent (Fig. 5). After 4 h of culture, all three
measured mRNAs were reduced by about 40^50% with no
statistically signi¢cant di¡erences between them. However, ad-
ditional culture of intestinal explants revealed signi¢cant dif-
ferences between EGF and TGF-K mRNA levels. The degra-
dation of TGF-K mRNA was markedly faster in comparison
with EGF mRNA. Transcript levels of TGF-K were reduced
to 15% of starting value at 8 h of culture, and an additional 8
h of culture (total 16 h) brought TGF-K transcript levels to
2% of the starting level. In contrast, EGF mRNA degradation
was much slower. Transcript levels were reduced after the ¢rst
4 h of culture to 40% of starting values, then remained almost
unchanged during the culture (39% and 34% of starting value
after 8 and 16 h of culture, respectively). The stability pattern
of EGF-R mRNA revealed a gradual decrease of EGF-R
transcripts during in vitro culture. Transcript levels were
53%, 40% and 25% of the initial amount at 4 h, 8 h and
16 h of culture, respectively
4. Discussion
The presence of EGF and TGF-K peptides in the gastro-
intestinal tract of suckling rats is well established. However,
the origin, physiological role and interactions of these growth
factors are not completely understood. Previously, we have
shown that total content of TGF-K in the small intestine of
suckling rats is similar to the total content of EGF, however,
the distribution is di¡erent. About 90% of total TGF-K pep-
tide is detected in intestinal mucosa and only 10% in intestinal
luminal contents [18]. In contrast to this, luminal EGF level in
suckling rats represents about 40^70% of the total intestinal
EGF content [16,17]. The major source of intestinal EGF
content is milk-borne EGF, whereas TGF-K is not detectable
in rat milk and intestinal TGF-K content is probably the
result of endogenous synthesis by the small intestine and pan-
creatic excretion. Indeed, fasting (up to 18 h) of suckling rats
reduced intestinal TGF-K content by only 25%, whereas total
EGF content is decreased by almost 90% [16^18]. In spite of
this signi¢cant decrease, small amounts of EGF peptide are
still detectable in the intestinal mucosa of fasted suckling rats.
These observations prompted the question of whether devel-
oping small intestine has the potential to synthesize not only
TGF-K but also EGF peptide. The major goal of this study
was to quantify and compare the steady-state levels of EGF,
TGF-K and EGF-R mRNAs in the small intestine of suckling
rats. Moreover, results from mRNA stability studies in intes-
tinal organ culture are presented.
Transcript levels of EGF and TGF-K in developing small
intestine have not been well characterized. Originally, the
presence of TGF-K mRNA transcripts was found in the gas-
trointestinal tract from adult rodents only, and the expression
of EGF mRNA was not detected in either adult [41^44] or
suckling gastrointestinal tract [45] at all. In all these reports,
EGF and TGF-K gene expression was studied using Northern
blot analysis. Miettinen [46] detected the presence of TGF-K
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Fig. 5. The stability of TGF-K, EGF and EGF-R transcripts in the
in vitro intestinal culture. Intestinal explants from 10-day-old suck-
ling rats were incubated in culture medium supplemented with acti-
nomycin D (10 Wg/ml) for up to 16 h and total RNA was extracted
at the times shown. Transcript levels were measured by RT compet-
itive-PCR assay. Combined data from four experiments are shown.
Individual points are the means þ S.E.M. from 8^10 samples.
Fig. 4. Expression of TGF-K, EGF and EGF-R mRNAs in the in
vitro intestinal culture. Intestinal explants from 10-day-old suckling
rats were incubated in culture medium for up to 16 h and total
RNA was extracted at the times shown. Transcript levels were
measured by RT competitive-PCR assay. Combined data from four
experiments are shown. Individual points are the means þ S.E.M.
from 8^10 samples.
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and EGF transcripts in human fetal intestine by using a more
sensitive ribonuclease protection assay and reverse transcrip-
tion-polymerase chain reaction (RT-PCR) technique. Her ob-
servation suggested a higher abundance of TGF-K transcripts
in human fetal intestine in comparison with EGF mRNA.
However, no accurate quanti¢cation was performed. Earlier
studies from our laboratory have shown the presence and
cellular localization of both EGF and TGF-K mRNAs in
the small intestine of suckling and adult rats [24]. Using an
in situ hybridization technique, we have shown that the intes-
tinal crypt epithelium is the major site of EGF and TGF-K
transcripts in both suckling and adult rats. Despite the same
histological localization of EGF and TGF-K mRNAs, there
are signi¢cant di¡erences in the intensity of the detected sig-
nals. Strong signals for the presence of both EGF and TGF-K
mRNAs were observed in the small intestine from adult rats.
In suckling rats, however, the EGF mRNA signal was very
low or absent, whereas TGF-K mRNA signal was detected in
all samples with markedly higher intensity.
Based on these semiquantitative observations, we decided to
clarify the steady-state levels of EGF and TGF-K transcripts
in the small intestine of suckling rats. As mentioned above,
the abundance of EGF mRNA in developing small intestine is
extremely low, therefore it was necessary to establish a very
sensitive method to detect and quantify EGF mRNA in this
tissue. PCR based detection of the message seems to be a very
useful approach; however, simple RT-PCR is not accurate
enough for quanti¢cation of mRNA levels. The introduction
of RT competitive-PCR assay enabled us to measure gene
expression of low abundant messages in all samples with
high accuracy and good reproducibility. Results from these
measurements showed that in suckling rats, intestinal TGF-
K mRNA level is about 10-fold higher in comparison with
EGF mRNA level. Despite low transcript level, EGF
mRNA is detectable in all intestinal samples, suggesting the
potential of developing small intestine to produce EGF pep-
tide. High expression of TGF-K mRNA, interestingly, corre-
sponds with previously measured high levels of TGF-K pep-
tide level in this tissue, thus supporting the hypothesis that the
developing jejunum is an important source of TGF-K [18].
The presence of TGF-K transcripts in intestinal crypt epithe-
lium followed by translation into peptide in these cells sug-
gests that TGF-K is involved in control of intestinal prolifer-
ation and migration during development, rather than in
maturation of intestinal epithelium. The amount of EGF
mRNA in the jejunum of suckling rats is about 10 times lower
in comparison with TGF-K mRNA, suggesting that intestinal
EGF gene expression under normal conditions may be down-
regulated in the presence of milk-borne EGF.
The presence of a speci¢c EGF-receptor is a prerequisite for
any action of either EGF or TGF-K peptides. In the develop-
ing small intestine, the presence of EGF receptor molecule has
been reported, but its gene expression was not studied in rats.
In the suckling mouse, an EGF-receptor was detected in the
small intestine throughout the entire postnatal period [21]. In
developing rats, immunoreactive EGF-receptors have been lo-
calized to the basolateral membrane of enterocytes from both
crypt and villus in fetal, suckling and adult jejunum. The
abundance of a 170-kDa EGF-receptor band, measured by
Western blot, was highest in fetal jejunum and decreased after
the suckling period [23]. In our current study we also deter-
mined the EGF-R mRNA level in jejunum of suckling rats.
Intestinal EGF-R mRNA levels were signi¢cantly higher than
transcript levels of both growth factors.
Signi¢cant di¡erences in EGF and TGF-K mRNA gene
expression prompted further study of the regulation of
mRNA level of these two structurally related growth factors
in developing small intestine. The abundance of mRNA is
controlled by both transcription and mRNA stability. In
our study, we used the combination of primary intestinal cul-
ture technique with the RT competitive-PCR assay to evaluate
EGF and TGF-K mRNA stability. Results from these mea-
surements revealed considerable di¡erences between these
mRNAs. Stability of the TGF-K transcript is remarkably low-
er than the stability of EGF mRNA. High degradation rate of
TGF-K mRNA correlates with signi¢cant increase of TGF-K
mRNA production during in vitro culture of intestinal ex-
plants, suggesting rapid turnover of intestinal TGF-K
mRNA. Interestingly, a signi¢cantly lower EGF mRNA
steady-state level in the small intestine of suckling rats is ac-
companied by markedly higher mRNA stability and lower in
vitro transcription.
In conclusion, the present data demonstrate signi¢cant dif-
ferences in gene expression of EGF and TGF-K mRNAs in
the developing small intestine of suckling rats. Moreover, high
abundance of EGF-R mRNA is described. EGF and TGF-K
are structurally related mitogenic factors that coordinate
growth and renewal of the gastrointestinal tract. The mecha-
nism of action of these two growth factors in developing small
intestine is not clear but considerable di¡erences in the origin
and distribution of EGF and TGF-K are apparent. Markedly
high intestinal TGF-K mRNA levels accompanied by the pres-
ence of mature TGF-K peptide in intestinal mucosa, support
the hypothesis that TGF-K may be the primary ligand of
EGF-receptor in the developing intestine. Milk-borne EGF
likely plays an important role in the apparent protective e¡ect
of breast milk. After the weaning period, endogenous EGF
production is encreased in submandibulary glands, duodenum
and jejunum. These changes may contribute both directly and
via adrenal and thyroid glands to maturation of gastrointes-
tinal functions.
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